RFFTX
Price
$19.08
Change
+$0.08 (+0.42%)
Updated
Apr 25 closing price
Net Assets
47.98B
SRJYX
Price
$19.69
Change
+$0.08 (+0.41%)
Updated
Apr 25 closing price
Net Assets
3.76B
Ad is loading...

RFFTX vs SRJYX

Header iconRFFTX vs SRJYX Comparison
Open Charts RFFTX vs SRJYXBanner chart's image
American Funds 2035 Trgt Date Retire R6
Price$19.08
Change+$0.08 (+0.42%)
VolumeN/A
Net Assets47.98B
JPMorgan SmartRetirement® 2035 R6
Price$19.69
Change+$0.08 (+0.41%)
VolumeN/A
Net Assets3.76B
RFFTX vs SRJYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RFFTX vs. SRJYX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RFFTX is a Hold and SRJYX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RFFTX has more cash in the bank: 48B vs. SRJYX (3.76B). SRJYX pays higher dividends than RFFTX: SRJYX (2.97) vs RFFTX (1.99). RFFTX was incepted earlier than SRJYX: RFFTX (16 years) vs SRJYX (10 years). SRJYX (0.41) is less costly to investors than RFFTX (0.34). RFFTX has a lower initial minimum investment than SRJYX: RFFTX (250) vs SRJYX (15000000). RFFTX annual gain was more profitable for investors over the last year : 7.07 vs. SRJYX (6.55). RFFTX return over 5 years is better than : 41.44 vs. SRJYX (27.17).
RFFTXSRJYXRFFTX / SRJYX
Total Expense Ratio0.340.4085%
Annual Report Gross Expense Ratio0.340.4183%
Fund Existence16 years10 years-
Gain YTD0.210-0.304-69%
Front LoadN/AN/A-
Min. Initial Investment250150000000%
Min. Initial Investment IRAN/AN/A-
Net Assets48B3.76B1,277%
Annual Yield % from dividends1.992.9767%
Returns for 1 year7.076.55108%
Returns for 3 years15.7312.61125%
Returns for 5 years41.4427.17153%
Returns for 10 years50.5625.93195%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA3.890.12
+3.18%
Inventiva SA
FCX37.35-0.28
-0.74%
Freeport-McMoran
ATRC33.40-0.35
-1.04%
AtriCure
SRPT60.44-1.32
-2.14%
Sarepta Therapeutics
ONCY0.56-0.03
-4.65%
Oncolytics Biotech